Good cash flows from the launch of cholesterol-lowering drug Zetia in December could help Glenmark Pharma trim its debt significantly by the end of the year says Pharma Analyst Surajit Pal of Prabhudas Lilladher. Glenmark will enjoy 134 days of exclusivity from the launch of the drug.